المؤلفون: Aslı Gamze Şener, Firdevs Topal, Elif Saritas Yuksel, Bilal Olcay Peker

المصدر: Microbiology and Immunology. 65:171-177

مصطلحات موضوعية: medicine.medical_specialty, Genotype, Anti-nuclear antibody, Hepatitis C virus, Immunology, Hepacivirus, medicine.disease_cause, Antiviral Agents, Microbiology, Gastroenterology, Polyethylene Glycols, Telaprevir, 03 medical and health sciences, chemistry.chemical_compound, Virology, Internal medicine, Boceprevir, Ribavirin, medicine, Humans, Hepatitis Antibodies, 030304 developmental biology, 0303 health sciences, biology, 030306 microbiology, Antibody titer, Hepatitis C, Chronic, Recombinant Proteins, Titer, Treatment Outcome, chemistry, Antibodies, Antinuclear, biology.protein, Antibody, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645234dce2c66ec2bec6b56124e444e3Test
https://doi.org/10.1111/1348-0421.12879Test

المؤلفون: João Paulo Vilela Rodrigues, Ana de Lourdes Candolo Martinelli, Leonardo Régis Leira Pereira, Silvana Gama Florencio Chachá, Maurílio de Souza Cazarim

المصدر: Cadernos de Saúde Pública v.36 n.2 2020
Cadernos de Saúde Pública
Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
Cadernos de Saúde Pública, Volume: 36, Issue: 2, Article number: e00036619, Published: 31 JAN 2020
Cadernos de Saúde Pública, Vol 36, Iss 2

مصطلحات موضوعية: economía, Economics, Cost-Benefit Analysis, lcsh:Medicine, Hepacivirus, Telaprevir, Polyethylene Glycols, chemistry.chemical_compound, Toma de Decisiones, 0302 clinical medicine, 030212 general & internal medicine, hepatitis c, health care economics and organizations, lcsh:Public aspects of medicine, Hepatitis C, Cost-effectiveness analysis, University hospital, Recombinant Proteins, Hepatite C, Inhibidores de Proteasas, Pharmaceuticals, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Quality-Adjusted Life Years, Oligopeptides, Brazil, medicine.drug, Healthcare system, medicine.medical_specialty, Genotype, Proline, Tomada de Decisões, Decision Making, preparaciones farmacéuticas, Economia, Interferon alpha-2, Antiviral Agents, Economía, 03 medical and health sciences, Boceprevir, Internal medicine, Ribavirin, medicine, Humans, Protease Inhibitors, Inibidores de Proteases, business.industry, lcsh:R, Public Health, Environmental and Occupational Health, Interferon-alpha, lcsh:RA1-1270, Hepatitis C, Chronic, medicine.disease, Clinical trial, chemistry, inhibidores de proteasas, Preparaciones Farmacéuticas, toma de decisiones, business, Preparações Farmacêuticas

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61669eadc2205d4a5b03d11f0e7dc0bcTest
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2020000205006Test

المؤلفون: Erica Villa, Tommaso Trenti, Valentina Pecoraro, Elisabetta Cariani

المصدر: European Journal of Clinical Investigation. 46:737-748

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Proline, Clinical Biochemistry, Antiviral Agents, Biochemistry, Polyethylene Glycols, Telaprevir, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Boceprevir, hepatitis C, meta-analysis, Drug Therapy, Combination, Female, Hepatitis C, Chronic, Humans, Interferon-alpha, Middle Aged, Recombinant Proteins, Ribavirin, Treatment Outcome, Medicine (all), Internal medicine, medicine, 030212 general & internal medicine, Adverse effect, business.industry, General Medicine, Hepatitis C, Odds ratio, medicine.disease, Discontinuation, chemistry, Meta-analysis, 030211 gastroenterology & hepatology, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::499066f0369dc14eb3e3e6b7bb753decTest
https://doi.org/10.1111/eci.12656Test

المؤلفون: Astrid M. Newsum, Sebastiaan J. Hullegie, Bart J. A. Rijnders, F. N. Lauw, Jan van der Meer, Mark A. A. Claassen, Joop E. Arends, Dirk Posthouwer, Arne van Eeden, Peter P. Koopmans, Wouter F W Bierman, Eliane M. S. Leyten, Guido E.L. van den Berk, Clemens Richter

المساهمون: RS: FHML non-thematic output, Med Microbiol, Infect Dis & Infect Prev, MUMC+: DA MMI Staf (9), Interne Geneeskunde, Infectious diseases, Other departments

المصدر: Journal of Hepatology, 64(4), 807-812. Elsevier Science
Journal of Hepatology, 64, 4, pp. 807-12
Journal of Hepatology, 64, 807-12
Journal of hepatology, 64(4), 807-812. Elsevier
Journal of Hepatology, 64(4), 807-812. ELSEVIER SCIENCE BV

مصطلحات موضوعية: Male, CLEARANCE, medicine.disease_cause, THERAPY, RECOMMENDATIONS, Polyethylene Glycols, chemistry.chemical_compound, 0302 clinical medicine, Pegylated interferon, Clinical endpoint, Prospective Studies, 030212 general & internal medicine, POSITIVE PATIENTS, GENOTYPE 1, MEN, Hepatitis C, Middle Aged, Recombinant Proteins, Acute Disease, HCV, Drug Therapy, Combination, Female, TRIAL, 030211 gastroenterology & hepatology, medicine.drug, Adult, medicine.medical_specialty, Proline, Hepatitis C virus, Acute hepatitis C, Alpha interferon, VIRUS-INFECTION, Interferon alpha-2, Antiviral Agents, 03 medical and health sciences, Internal medicine, Boceprevir, Ribavirin, medicine, Humans, PEGYLATED INTERFERON-ALPHA-2B, Intention-to-treat analysis, Hepatology, business.industry, Interferon-alpha, HIV, medicine.disease, Treatment, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], chemistry, Immunology, Quality of Life, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d990698bc3d0b842e4b8df7527c7beTest
https://doi.org/10.1016/j.jhep.2015.12.004Test

المؤلفون: Lúcia de Araújo Costa Beisl Noblat, Júnior André da Rosa, João Paulo Vilela Rodrigues, Ana de Lourdes Candolo Martinelli, Marysabel Pinto Telis Silveira, Lenyta Oliveira Gomes, Mariane D Ávila Vecchi, Silvana Gama Florencio Chachá, Marina Rodrigues Teixeira, Leonardo Régis Leira Pereira, Mareni Rocha Farias, Carine Raquel Blatt, Alberi Adolfo Feltrin, Jane Meire M. Carneiro

المصدر: Revista do Instituto de Medicina Tropical de São Paulo; Vol. 60 (2018); e29
Revista do Instituto de Medicina Tropical de São Paulo; v. 60 (2018); e29
Revista do Instituto de Medicina Tropical de São Paulo
Instituto de Medicina Tropical (IMT)
instacron:IMT
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Revista do Instituto de Medicina Tropical de São Paulo, Volume: 60, Article number: e29, Published: 28 JUN 2018
Revista do Instituto de Medicina Tropical de São Paulo, Vol 60, Iss 0 (2018)

مصطلحات موضوعية: Male, medicine.medical_specialty, lcsh:Arctic medicine. Tropical medicine, Genotype, Proline, lcsh:RC955-962, Decision Making, Alpha interferon, Hepacivirus, Interferon alpha-2, Antiviral Agents, Polyethylene Glycols, Telaprevir, High cost medicines, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Clinical Protocols, Internal medicine, Boceprevir, Ribavirin, medicine, Humans, INIBIDORES DE ENZIMAS, 030212 general & internal medicine, Adverse effect, Real life studies, Retrospective Studies, business.industry, Interferon-alpha, Hepatitis C, Hepatitis C, Chronic, Middle Aged, Protease inhibitors, medicine.disease, Recombinant Proteins, Discontinuation, Clinical trial, chemistry, Drug Therapy, Combination, Female, Original Article, 030211 gastroenterology & hepatology, Chronic hepatitis C treatment, business, Oligopeptides, medicine.drug

وصف الملف: application/pdf; application/xml; text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::483ea6dd53865c31215b795f2459d7cdTest
https://www.revistas.usp.br/rimtsp/article/view/148079Test

المؤلفون: Caroline Solas, Isabelle Poizot-Martin, Eric Bellissant, Lionel Piroth, Patrizia Carrieri, Jade Ghosn, Marc Bourlière, Philippe Colson, Jean-Michel Molina, Alain Renault, Rodolphe Garraffo, Philippe Halfon, Laurent Alric, Alissa Naqvi

المساهمون: Département de Recherche CLinique, CISIH-Sud, Hôpital Sainte-Marguerite, Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale ( SESSTIM - U912 INSERM - AMU - IRD ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut de Recherche pour le Développement ( IRD ) -Aix Marseille Université ( AMU ), Department of clinical and biological pharmacology and pharmacovigilance, CHU Pontchaillou [Rennes], Centre d'Investigation Clinique [Rennes] ( CIC ), Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Service de pharmacologie, Hôpital Pasteur [Nice] ( CHU ) -CHU Nice, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes ( URMITE ), Institut de Recherche pour le Développement ( IRD ) -Aix Marseille Université ( AMU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -IFR48, INSB-INSB-Centre National de la Recherche Scientifique ( CNRS ), Département d'infectiologie (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ), Agroécologie [Dijon], Institut National de la Recherche Agronomique ( INRA ) -Université de Bourgogne ( UB ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement, Service de Pharmacocinétique et de Toxicologie, Assistance Publique - Hôpitaux de Marseille ( APHM ) - Hôpital de la Timone [CHU - APHM] ( TIMONE ), Centre de Recherches en Oncologie biologique et Oncopharmacologie ( CRO2 ), Aix Marseille Université ( AMU ) - Hôpital de la Timone [CHU - APHM] ( TIMONE ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Service de Pharmacologie, Service d'hépato-gastro-entérologie, Assistance Publique - Hôpitaux de Marseille ( APHM ), Internal Medicine and Infectious Diseases Department, European Hospital and Alphabio Laboratory, Infection à VIH, réservoirs, diversité génétique et résistance aux antirétroviraux (ARV) ( EA 7327 ), Université Paris Descartes - Paris 5 ( UPD5 ), Pharmacochimie et Pharmacologie Pour le Développement ( PHARMA-DEV ), Université Toulouse III - Paul Sabatier ( UPS ), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Recherche pour le Développement (IRD)-Centre National de la Recherche Scientifique ( CNRS ), Service de Maladies Infectieuses [Nice], Observatoire Régional de la Santé Provence Alpes Côte d'Azur, ORS PACA, Service des Maladies Infectieuses et Tropicales [CHU Saint Louis], Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Génétique et Ecologie des Virus, Génétique des Virus et Pathogénèse des Maladies Virales, Université Paris Diderot - Paris 7 ( UPD7 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Immuno-hématologie clinique [Hôpital Sainte Marguerite - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Pasteur [Nice] (CHU), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), Hôpital de la Timone [CHU - APHM] (TIMONE), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre de Recherches en Oncologie biologique et Oncopharmacologie (CRO2), Aix Marseille Université (AMU)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'hépatologie et de gastroentérologie [Hôpital Saint-Joseph - Marseille], Aix Marseille Université (AMU)-Hôpital Saint-Joseph [Marseille], Hôpital Européen [Fondation Ambroise Paré - Marseille], Infection à VIH, réservoirs, diversité génétique et résistance aux antirétroviraux (ARV) (EA 7327), Université Paris Descartes - Paris 5 (UPD5), Service de Médecine Interne - Immunologie Clinique [AP-HP Bicêtre], AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Pharmacochimie et Biologie pour le Développement (PHARMA-DEV), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Hôpital Archet 2 [Nice] (CHU), Observatoire régional de la santé Provence-Alpes-Côte d'Azur [Marseille] (ORS PACA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), French National Agency for Research on AIDS and Viral Hepatitis (ANRS), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )-Assistance Publique - Hôpitaux de Marseille (APHM), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), INSB-INSB-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC), Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Hôpital Pasteur [Nice] (CHU)-Centre Hospitalier Universitaire de Nice (CHU Nice), Institut National de la Recherche Agronomique (INRA)-Université de Bourgogne (UB)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement, Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Assistance Publique - Hôpitaux de Marseille (APHM), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), French National Agency for Research on AIDS and Viral Hepatitis(ANRS), Jonchère, Laurent, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP)

المصدر: HIV Clinical Trials
HIV Clinical Trials, Thomas Land Publishers, 2016, 17 (2), pp.63-71. 〈10.1080/15284336.2015.1135553〉
HIV Clinical Trials, 2016, 17 (2), pp.63-71. ⟨10.1080/15284336.2015.1135553⟩
HIV Clinical Trials, Thomas Land Publishers, 2016, 17 (2), pp.63-71. ⟨10.1080/15284336.2015.1135553⟩

مصطلحات موضوعية: Male, HIV Infections, Hepacivirus, Pharmacology, Gastroenterology, Polyethylene Glycols, chemistry.chemical_compound, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Clinical endpoint, boceprevir, Pharmacology (medical), 030212 general & internal medicine, Univariate analysis, Coinfection, virus diseases, Middle Aged, Recombinant Proteins, 3. Good health, [ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Treatment Outcome, Infectious Diseases, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug Therapy, Combination, Female, 030211 gastroenterology & hepatology, medicine.drug, Adult, medicine.medical_specialty, Genotype, Proline, direct acting antiviral drug, Antiviral Agents, 03 medical and health sciences, Boceprevir, Internal medicine, Ribavirin, medicine, Humans, Adverse effect, HCV retreatment, business.industry, Interferon-alpha, [ SDV.SP.PHARMA ] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Raltegravir, HIV/HCV coinfection, Atazanavir, Regimen, chemistry, HIV-1, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a63ce0f51d5e30be9c60c5af64f6cba7Test
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01299973/documentTest

المؤلفون: Callefi, Luciana Azevedo, Villela-Nogueira, Cristiane Alves, Tenore, Simone de Barros, Carnauba-Junior, Dimas, Moraes Coelho, Henrique Sergio, Pinto, Paulo de Tarso A., Nabuco, Leticia Cancella, Pessoa, Mario Guimaraes, Cardoso Gomes Ferraz, Maria Lucia [UNIFESP], Abrao Ferreira, Paulo Roberto [UNIFESP], Candolo Martinelli, Ana de Lourdes, Florencio Chacha, Silvana Gama, Paiva Ferreira, Adalgisa de Souza, de Macedo Bisio, Alessandra Porto, Brandao-Mello, Carlos Eduardo, Alvares-Da-Silva, Mario Reis, Reuter, Tania, Alexandra, Claudia, Ivantes, Pontes, Perez, Renata de Mello, Jacintho Mendes-Correa, Maria Cassia

المصدر: Clinics, Volume: 72, Issue: 6, Pages: 378-385, Published: JUN 2017
Clinics
Clinics, Vol 72, Iss 6, Pp 378-385
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Clinics; v. 72 n. 6 (2017); 378-385
Clinics; Vol. 72 Núm. 6 (2017); 378-385
Clinics; Vol. 72 No. 6 (2017); 378-385
Universidade de São Paulo (USP)
instacron:USP
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP

مصطلحات موضوعية: Male, Cirrhosis, medicine.medical_treatment, Hepacivirus, Telaprevir, Antivirais, Polyethylene Glycols, chemistry.chemical_compound, 0302 clinical medicine, Genotype, Meia-idade, Chronic, Hepatite C crônica, lcsh:R5-920, General Medicine, Hepatitis C, Middle Aged, Clinical Science, Recombinant Proteins, Treatment Outcome, RNA, Viral, Female, Safety, 0305 other medical science, lcsh:Medicine (General), Oligopeptides, Brazil, medicine.drug, medicine.medical_specialty, Proline, 030231 tropical medicine, Therapeutics, Interferon alpha-2, Proteínas recombinantes, Antiviral Agents, 03 medical and health sciences, Boceprevir, Internal medicine, medicine, Humans, Protease Inhibitors, Adverse effect, Aged, 030505 public health, Protease, business.industry, Ribavirin, Brasil, Interferon-alpha, Hepatitis C, Chronic, Protease inhibitors, medicine.disease, Cross-Sectional Studies, chemistry, Immunology, business, RNA viral

وصف الملف: text/html; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633728cef1aa21a6cbfc47fdf1eba9d3Test
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000600378&lng=en&tlng=enTest

المؤلفون: Márcia Guimarães Villanova, Rodrigo de Carvalho Santana, Leonardo Régis Leira Pereira, João Paulo Vilela Rodrigues, Ana de Lourdes Candolo Martinelli, Fernanda Fernandes Souza, Roberta Chaves Araújo, Silvana Gama Florencio Chachá

المصدر: Revista da Sociedade Brasileira de Medicina Tropical v.51 n.2 2018
Revista da Sociedade Brasileira de Medicina Tropical
Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT
Revista da Sociedade Brasileira de Medicina Tropical, Vol 51, Iss 2, Pp 146-154
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Revista da Sociedade Brasileira de Medicina Tropical, Volume: 51, Issue: 2, Pages: 146-154, Published: APR 2018

مصطلحات موضوعية: Male, Cirrhosis, Hepacivirus, medicine.disease_cause, Telaprevir, Polyethylene Glycols, chemistry.chemical_compound, 0302 clinical medicine, Pegylated interferon, Medicine, 030212 general & internal medicine, Boceprevir, Incidence (epidemiology), virus diseases, Hepatitis C, Middle Aged, Recombinant Proteins, Infectious Diseases, Treatment Outcome, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Female, Oligopeptides, medicine.drug, Microbiology (medical), Adult, medicine.medical_specialty, lcsh:Arctic medicine. Tropical medicine, Drug-Related Side Effects and Adverse Reactions, Genotype, Proline, lcsh:RC955-962, Hepatitis C virus, Adverse drug reaction, Interferon alpha-2, Antiviral Agents, 03 medical and health sciences, Internal medicine, Ribavirin, Humans, Protease Inhibitors, Aged, Retrospective Studies, business.industry, Interferon-alpha, Hepatitis C, Chronic, medicine.disease, PROTEÍNAS RECOMBINANTES, digestive system diseases, chemistry, Parasitology, business, Hepatitis C vírus

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b74ca9c890639249cb5851cea5b98646Test
https://pubmed.ncbi.nlm.nih.gov/29768546Test

المؤلفون: Bruce R. Bacon, Clifford A. Brass, K. Rajender Reddy, S.C. Gordon, Ke-Qin Hu, Janice K. Albrecht, Ira M. Jacobson, Eric Lawitz, Maria Buti, Jean-Pierre Bronowicki, Margaret Burroughs, Lisa D. Pedicone, Fred Poordad

المصدر: Journal of Clinical Gastroenterology. 48:435-443

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Genotype, Proline, viruses, Hepatitis C virus, Treatment outcome, Hepacivirus, Interferon alpha-2, medicine.disease_cause, Antiviral Agents, Gastroenterology, Polyethylene Glycols, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Chronic hepatitis, Recurrence, Internal medicine, Boceprevir, Ribavirin, medicine, Humans, Treatment Failure, 030212 general & internal medicine, Aged, Retrospective Studies, business.industry, Interferon-alpha, virus diseases, Hepatitis C, Chronic, Middle Aged, Viral Load, Recombinant Proteins, digestive system diseases, 3. Good health, Treatment Outcome, chemistry, Virologic response, Drug Therapy, Combination, Female, 030211 gastroenterology & hepatology, business, Viral load

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48cba20766010fd08cb84bd3d3de970bTest
https://doi.org/10.1097/mcg.0000000000000000Test

المؤلفون: Javier Murillas, M. Cervantes, José Mallolas, S. López-Calvo, Josep M. Guardiola, Montserrat Laguno, Jordi Navarro, Carmen Cifuentes, Anna Cruceta, Ana Carrero, M.A. Von Wichmann, Juan A. Pineda, María Martínez-Rebollar, Elisabeth Deig, J.L. Gómez-Sirvent, Antoni Jou, E. Van den Eynde, A. Tapiz, Marisa Montes, J.D. Ruiz-Mesa, S. Veloso, E de Lazzari

المساهمون: [Laguno, M.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [Martinez-Rebollar, M.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [Cruceta, A.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [de lazzari, E.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [Mallolas, J.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [Von Wichmann, M. A.] Hosp Univ Donostia, Donostia San Sebastian, Spain, [Van den Eynde, E.] Hosp Univ Bellvitge, Bellvitge, Spain, [Navarro, J.] Hosital Univ Vall dHebron, Barcelona, Spain, [Cifuentes, C.] Hosp Son Llatzer, Palma De Mallorca, Spain, [Murillas, J.] Hosp Son Espases, Palma De Mallorca, Spain, [Veloso, S.] Hosp Univ Joan XXIII, Tarragona, Spain, [Guardiola, J. M.] Hosp Santa Creu & Sant Pau, Barcelona, Spain, [Jou, A.] Hosp Badalona Germans Trias & Pujol, Badalona, Spain, [Gomez-Sirvent, J. L.] Hosp Univ Canarias, Tenerife, Spain, [Cervantes, M.] Corp Sanitaria Parc Tauli, Sabadell, Spain, [Pineda, J. A.] Hosp Univ Valme, Seville, Spain, [Lopez-Calvo, S.] Hosp Univ A Coruna, La Coruna, Spain, [Carrero, A.] Hosp Univ Gregorio Maranon, Madrid, Spain, [Montes, M. L.] Hosp Univ La Paz, Madrid, Spain, [Deig, E.] Hosp Granollers, Granollers, Spain, [Tapiz, A.] Fundacio Althaia, Manresa, Spain, [Ruiz-Mesa, J. D.] Hosp Reg, Malaga, Spain, Merck: BOC-HIV Study, Instituto de Salud Carlos III, Ministerio Economia y Competitividad

المصدر: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International Journal of Infectious Diseases, Vol 53, Iss C, Pp 46-51 (2016)
Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: Peptidasas, Male, Cirrhosis, HIV Infections, interferón alfa, HCV genotype 1, Hepacivirus, Phase-2 trial, Oral inhibitors, Gastroenterology, Telaprevir, Polyethylene Glycols, 0302 clinical medicine, Pegylated interferon, estudios prospectivos, ribavirina, PEG-IFN/RBV plus BOC therapy, Clinical endpoint, VIH-VHC, Prospective Studies, mediana edad, Boceprevir, PEG-IFN therapy, Coinfection, farmacoterapia, virus diseases, General Medicine, adulto, Genotype 1, Interferon, retratamiento, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Safety, Microbiology (medical), medicine.medical_specialty, 616.9, Genotype, Proline, Antiviral Agents, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, Drug Therapy, Humans, proteínas recombinantes, Pacients, Inhibidores orales, Adverse effect, HIV–HCV experienced patients, medicine.disease, digestive system diseases, Discontinuation, chemistry, proteínas víricas no estructurales, genotipo, Teràpia PEG-IFN, glicoles de polietileno, antivíricos, humanos, Interferó, Viral Nonstructural Proteins, medicine.disease_cause, Genotipo 1, chemistry.chemical_compound, prolina, PEG-IFN/RBV + BOC therapy, 030212 general & internal medicine, coinfección, resultado del tratamiento, Cohort, HIV-HCV experienced patients, Middle Aged, Hepatitis C, Recombinant Proteins, Infectious Diseases, Treatment Outcome, Retreatment, Pacientes, Female, Terapia PEG-IFN, medicine.drug, Adult, Patients, Hepatitis C virus, Coinfected patients, Interferon-alpha-2b, Re-treatment, Genotip 1, Internal medicine, Ribavirin, medicine, Triple-therapy, lcsh:RC109-216, PEG-IFN/RBV+BOC therapy, Espanya, business.industry, Interferon-alpha, Proteasa, Protease, Surgery, Inhibidors orals, RBV + BOC, Spain, infecciones por VIH, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a02d557208f7cecc8a3022e84c4e80fTest
http://hdl.handle.net/2445/160558Test